Lupin Recalls Lisinopril Tablets Due to Foreign Tablet Mix-Up
Lupin Pharmaceuticals is recalling 25,944 bottles of Lisinopril 30 mg tablets because a 5 mg tablet was found mixed into a 30 mg bottle.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The hazard is a mix-up of a lower-dose tablet (5 mg) into a higher-dose bottle (30 mg), which is a labeling/packaging error rather than a high-risk contamination or structural defect.
Plain-English summary
Lupin Pharmaceuticals, Inc. is recalling 25,944 bottles of Lisinopril Tablets USP, 30 mg, 100-count. The recall was initiated after a product complaint indicated that one 5 mg lisinopril tablet was found inside a bottle intended to contain only 30 mg tablets.
The affected product is identified by Lot # Q900580 with an expiration date of 9/2021. The recall covers distribution across the U.S.A. nationwide. The specific NDC for the recalled 30 mg, 100-count bottle is 68180-982-01.
Consumers who have this specific lot of Lisinopril 30 mg tablets should stop using them and contact their pharmacist or healthcare provider for guidance on obtaining a replacement. The recall is classified as FDA Class II.
The recalled product
- Product
- LISINOPRIL (LISINOPRIL)
- Brand
- LISINOPRIL
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Category
- Drug — Prescription Drug
- Affected units
- 25,944
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: Q900580
- Exp 9/2021
UPCs (3)
- 0368180513018
- 0368180512028
- 0368180513032
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · LISINOPRIL
- HighLisinopril 10 mg Tablets Recalled for Metal Fragment Contamination
FDA (Drugs) · 2024-11-27
- HighLisinopril Tablets Recalled for Embedded Metal Contamination
FDA (Drugs) · 2022-09-21
- HighLupin Recalls Lisinopril Tablets Due to Foreign Tablet Presence
FDA (Drugs) · 2020-08-05
- HighLupin Recalls Lisinopril 5 mg Tablets Due to Product Mix-Up
FDA (Drugs) · 2020-06-17
- SevereLupin Recalls Lisinopril Tablets Due to Metal Contaminant
FDA (Drugs) · 2018-08-22
Same manufacturer · Lupin Pharmaceuticals Inc.
See all →- ModerateLupin Recalls Clobetasol Propionate Cream for Content Uniformity Failures
FDA (Drugs) · 2026-09-02
- SevereGlucagon Emergency Kit Recalled for Manufacturing Process Deviation
FDA (Drugs) · 2026-07-08
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- ModerateGanirelix acetate injection recalled after failing an impurity specification
FDA (Drugs) · 2025-12-17
Same hazard · foreign object
See all →- SevereOutshine Strawberry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Black Cherry Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Fruit Bars Grape Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02
- SevereOutshine Watermelon Fruit Bars Recalled for Potential Glass Contamination
FDA (Food) · 2026-09-02